BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 37141817)

  • 21. Role of DNA methylation and epigenetic silencing of HAND2 in endometrial cancer development.
    Jones A; Teschendorff AE; Li Q; Hayward JD; Kannan A; Mould T; West J; Zikan M; Cibula D; Fiegl H; Lee SH; Wik E; Hadwin R; Arora R; Lemech C; Turunen H; Pakarinen P; Jacobs IJ; Salvesen HB; Bagchi MK; Bagchi IC; Widschwendter M
    PLoS Med; 2013 Nov; 10(11):e1001551. PubMed ID: 24265601
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Methylated DNA collected by tampons--a new tool to detect endometrial cancer.
    Fiegl H; Gattringer C; Widschwendter A; Schneitter A; Ramoni A; Sarlay D; Gaugg I; Goebel G; Müller HM; Mueller-Holzner E; Marth C; Widschwendter M
    Cancer Epidemiol Biomarkers Prev; 2004 May; 13(5):882-8. PubMed ID: 15159323
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A Simple Cervicovaginal Epigenetic Test for Screening and Rapid Triage of Women With Suspected Endometrial Cancer: Validation in Several Cohort and Case/Control Sets.
    Herzog C; Marín F; Jones A; Evans I; Reisel D; Redl E; Schreiberhuber L; Paytubi S; Pelegrina B; Carmona Á; Peremiquel-Trillas P; Frias-Gomez J; Pineda M; Brunet J; Ponce J; Matias-Guiu X; de Sanjosé S; Alemany L; Olaitan A; Wong M; Jurkovic D; Crosbie EJ; Rosenthal AN; Bjørge L; Zikan M; Dostalek L; Cibula D; Sundström K; Dillner J; Costas L; Widschwendter M
    J Clin Oncol; 2022 Nov; 40(33):3828-3838. PubMed ID: 36001862
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The WID-EC test for the detection and risk prediction of endometrial cancer.
    Barrett JE; Jones A; Evans I; Herzog C; Reisel D; Olaitan A; Mould T; MacDonald N; Doufekas K; Newton C; Crosbie EJ; Bjørge L; Colombo N; Dostalek L; Costas L; Peremiquel-Trillas P; Ponce J; Matias-Guiu X; Zikan M; Cibula D; Wang J; Sundström K; Dillner J; Widschwendter M
    Int J Cancer; 2023 May; 152(9):1977-1988. PubMed ID: 36533702
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Integrated Epigenomics Analysis Reveals a DNA Methylation Panel for Endometrial Cancer Detection Using Cervical Scrapings.
    Huang RL; Su PH; Liao YP; Wu TI; Hsu YT; Lin WY; Wang HC; Weng YC; Ou YC; Huang TH; Lai HC
    Clin Cancer Res; 2017 Jan; 23(1):263-272. PubMed ID: 27507616
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Highly Discriminant Methylated DNA Markers for the Non-endoscopic Detection of Barrett's Esophagus.
    Iyer PG; Taylor WR; Johnson ML; Lansing RL; Maixner KA; Yab TC; Simonson JA; Devens ME; Slettedahl SW; Mahoney DW; Berger CK; Foote PH; Smyrk TC; Wang KK; Wolfsen HC; Ahlquist DA
    Am J Gastroenterol; 2018 Aug; 113(8):1156-1166. PubMed ID: 29891853
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Low-coverage whole-genome sequencing for the effective diagnosis of early endometrial cancer: A pilot study.
    Qiu H; Wang M; Cao T; Feng Y; Zhang Y; Guo R
    Heliyon; 2023 Sep; 9(9):e19323. PubMed ID: 37662762
    [TBL] [Abstract][Full Text] [Related]  

  • 28. DNA Methylation Markers for Detection of Cholangiocarcinoma: Discovery, Validation, and Clinical Testing in Biliary Brushings and Plasma.
    Yang JD; Ghoz H; Aboelsoud MM; Taylor WR; Yab TC; Berger CK; Cao X; Foote PH; Giama NH; Barr Fritcher EG; Mahoney DW; Moser CD; Smyrk TC; Kipp BR; Gores GJ; Roberts LR; Kisiel JB
    Hepatol Commun; 2021 Aug; 5(8):1448-1459. PubMed ID: 34430788
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identification of Endometrial Cancer-Specific microRNA Biomarkers in Endometrial Fluid.
    Yang J; Barkley JE; Bhattarai B; Firouzi K; Monk BJ; Coonrod DV; Zenhausern F
    Int J Mol Sci; 2023 May; 24(10):. PubMed ID: 37240034
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mutational analysis of cervical cytology improves diagnosis of endometrial cancer: A prospective multicentre cohort study.
    Reijnen C; van der Putten LJM; Bulten J; Snijders MPLM; Küsters-Vandevelde HVN; Sweegers S; Vos MC; van der Wurff AAM; Ligtenberg MJL; Massuger LFAG; Eijkelenboom A; Pijnenborg JMA
    Int J Cancer; 2020 May; 146(9):2628-2635. PubMed ID: 31523803
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The cost of diagnosing endometrial cancer: Quantifying the healthcare cost of an abnormal uterine bleeding workup.
    Warring SK; Borah B; Moriarty J; Gullerud R; Lemens MA; Destephano C; Sherman ME; Bakkum-Gamez JN
    Gynecol Oncol; 2022 Jan; 164(1):93-97. PubMed ID: 34756471
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ultrasound diagnosis of endometrial cancer by subjective pattern recognition in women with postmenopausal bleeding: prospective inter-rater agreement and reliability study.
    Wong M; Thanatsis N; Amin T; Bean E; Madhvani K; Jurkovic D
    Ultrasound Obstet Gynecol; 2021 Mar; 57(3):471-477. PubMed ID: 32621381
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Detection of MCM5 as a novel non-invasive aid for the diagnosis of endometrial and ovarian tumours.
    Stockley J; Akhand R; Kennedy A; Nyberg C; Crosbie EJ; Edmondson RJ
    BMC Cancer; 2020 Oct; 20(1):1000. PubMed ID: 33059604
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Plasma Methylated DNA Markers for Melanoma Surveillance.
    Berger CK; Taylor WR; Mahoney DW; Burger KN; Doering KA; Gonser AM; Cao X; Heilberger J; Gysbers BJ; Foote PH; Kottschade LA; Markovic SN; Lehman JS; Katerov VE; Allawi HT; Kisiel JB; Meves A
    JCO Precis Oncol; 2023 Sep; 7():e2300389. PubMed ID: 37883729
    [TBL] [Abstract][Full Text] [Related]  

  • 35. DNA methylation testing for endometrial cancer detection in urine, cervicovaginal self-samples and cervical scrapes.
    Wever BMM; van den Helder R; van Splunter AP; van Gent MDJM; Kasius JC; Trum JW; Verhoeve HR; van Baal WM; Hulbert A; Verhoef L; Heideman DAM; Lissenberg-Witte BI; van Trommel NE; Steenbergen RDM; Bleeker MCG
    Int J Cancer; 2023 Jul; 153(2):341-351. PubMed ID: 36912267
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Endometrial cancer and hyperplasia rate in women before menopause with abnormal uterine bleeding undergoing endometrial sampling.
    Gawron I; Łoboda M; Babczyk D; Ludwin I; Basta P; Pityński K; Ludwin A
    Przegl Lek; 2017; 74(4):139-43.. PubMed ID: 29696944
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Genome-wide DNA methylation analysis in obese women predicts an epigenetic signature for future endometrial cancer.
    Nagashima M; Miwa N; Hirasawa H; Katagiri Y; Takamatsu K; Morita M
    Sci Rep; 2019 Apr; 9(1):6469. PubMed ID: 31015518
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identification of DNA methylation associated gene signatures in endometrial cancer via integrated analysis of DNA methylation and gene expression systematically.
    Men C; Chai H; Song X; Li Y; Du H; Ren Q
    J Gynecol Oncol; 2017 Nov; 28(6):e83. PubMed ID: 29027401
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Potential of blood-based biomarker approaches in endometrium and breast cancer: a case-control comparison study.
    Schuhn A; Tobar TW; Gahlawat AW; Hauke J; Baumann L; Okun JG; Nees J
    Arch Gynecol Obstet; 2022 Nov; 306(5):1623-1632. PubMed ID: 35284957
    [TBL] [Abstract][Full Text] [Related]  

  • 40. New DNA Methylation Markers for Pancreatic Cancer: Discovery, Tissue Validation, and Pilot Testing in Pancreatic Juice.
    Kisiel JB; Raimondo M; Taylor WR; Yab TC; Mahoney DW; Sun Z; Middha S; Baheti S; Zou H; Smyrk TC; Boardman LA; Petersen GM; Ahlquist DA
    Clin Cancer Res; 2015 Oct; 21(19):4473-81. PubMed ID: 26023084
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.